It is currently recognized that degeneration of RGCs in human and experimental glaucoma is accompanied by a neuroinflammatory response, involving retinal microglial cells and increased production of inflammatory mediators, such as tumor necrosis factor (TNF) and interleukin-1β (IL-1β)4, 5, 6, 7. The gene discussed is TNF; the disease is glaucoma.